Effect of Cooling Rates on Shape and Crystal Size Distributions of Mefenamic Acid Polymorph in Ethyl Acetate

Mudalip, Siti Kholijah Abdul; Adam, Fatmawati; Parveen, J. Ruhena; Bakar, Mohd Rushdi Abu; Amran, Nur Syaira S.; Sulaiman, Siti Zubaidah; Man, Rohaida Che; Arshad, Zatul Iffah Mohd; Shaarani, Shalyda Md

doi:10.1088/1757-899x/205/1/012025

Cited by 3 publications

(2 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…165 The influence of cooling rate on the morphology as well as CSD of mefenamic acid polymorphs has also been studied. 211 Within a cooling rate range from 0.25 to 5 °C/min, it was observed that a cooling rate of 5 °C/min resulted in a narrow CSD with a high crystal aspect ratio. The MSZW (metastable zone width) of a solute molecule in a solvent is also affected by the cooling rate.…”

Section: Cocrystallizationmentioning

confidence: 96%

“…In the cooling crystallization of carbamazepine (CBZ) from 1-propyl alcohol, it was found that though both form III and form II of CBZ formed concomitantly during crystallization at a high cooling rate, a low cooling rate produced trigonal form II crystals . The influence of cooling rate on the morphology as well as CSD of mefenamic acid polymorphs has also been studied . Within a cooling rate range from 0.25 to 5 °C/min, it was observed that a cooling rate of 5 °C/min resulted in a narrow CSD with a high crystal aspect ratio.…”

Section: Parameters Influencing Solution Cocrystallizationmentioning

confidence: 99%

See 1 more Smart Citation

Pharmaceutical Cocrystals: A Perspective on Development and Scale-up of Solution Cocrystallization

Saha,

Ahangar,

Dar

et al. 2023

Crystal Growth & Design

View full text Add to dashboard Cite

Pharmaceutical cocrystals represent an emergent class of successful materials designed based on crystal engineering principles, in which the limitations of the extant drugs are addressed. Though the number of newly reported cocrystals is increasing exponentially, the scale-up of the cocrystallization process has not received enough attention. Solution cocrystallization techniques offer scalable processes that can utilize conventional crystallization machinery and process analytical technologies. The presence of multiple components and competing kinetics of the starting materials as well as the cocrystal make the cocrystallization process harder to study and control. This perspective emphasizes the importance of multicomponent phase diagrams for identifying operating regions in solution cocrystallization and discusses the effects of various operating parameters on the process kinetics. It also covers the intermolecular interactions involved in cocrystal development, cocrystallization methods, and quality control in pharmaceuticals. Furthermore, the role of the Design of Experiment and Quality by Design in scaling up the cocrystallization process efficiently is highlighted. A systematic decision tree has been proposed for scaling up the production of promising cocrystals using solution-based techniques, which can effectively address the current challenges in large-scale cocrystal production and help bring these potential materials to the market in the near future.

show abstract

Section: Cocrystallizationmentioning

confidence: 96%

Section: Parameters Influencing Solution Cocrystallizationmentioning

confidence: 99%